List of insiders holdings for Vera Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | Longitude Capital Partners IV LLC Longitude Prime Partners LLC Longitude Prime Fund L.P. Longitude Venture Partners IV L.P. Tammenoms Bakker Juliet 10% Owner | 2024-11-04 19:49:25 | 5,184,062 0 | 5,184,062 | Form 13D |
| 2 | ENRIGHT PATRICK G Director | 2025-06-25 20:07:16 | 0 3,596,593 | 3,596,593 | Form 4 |
| 3 | EMSTER KURT VON Director | 2021-05-18 20:10:03 | 17,828 2,960,231 | 2,978,059 | Form 4 |
| 4 | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. HEALY JAMES POWELL MICHAEL 10% Owner | 2024-03-26 19:57:53 | 2,813,837 0 | 2,813,837 | Form 13D |
| 5 | Sofinnova Venture Partners X L.P. Sofinnova Management X L.P. HEALY JAMES Katabi Maha Sofinnova Management X-A L.L.C. 10% Owner | 2024-03-26 19:57:53 | 2,813,837 0 | 2,813,837 | Form 13D |
| 6 | COMMODORE CAPITAL LP 10% Owner | 2024-11-14 16:10:28 | 2,475,000 0 | 2,475,000 | Form 13G |
| 7 | Ares Trading S.A. Merck KGaA MERCK SERONO S.A. 10% Owner | 2024-02-14 15:21:33 | 1,913,501 0 | 1,913,501 | Form 13G |
| 8 | Carlyle Group Inc. Abingworth LLP Abingworth Bioventures 8 LP Carlyle Holdings I GP Inc. Carlyle Holdings I GP Sub L.L.C. Carlyle Holdings I L.P. CG Subsidiary Holdings L.L.C. TC Group LLC Carlyle Investment Management LLC Carlyle Genesis UK LLC 10% Owner | 2023-08-02 17:01:28 | 1,872,764 0 | 1,872,764 | Form 13D |
| 9 | Fordyce Marshall PRESIDENT AND CEO | 2025-02-27 16:05:29 | 204,665 222,030 | 426,695 | Form 4 |
| 10 | Carter Jason S Chief Legal Officer | 2024-11-20 16:07:22 | 161,000 0 | 161,000 | Form 4 |
| 11 | Grant Sean CHIEF FINANCIAL OFFICER | 2025-02-20 16:08:57 | 147,037 5,000 | 152,037 | Form 4 |
| 12 | Young Joseph R SVP, FINANCE, CHIEF ACCT OFFCR | 2025-02-20 16:13:15 | 83,446 0 | 83,446 | Form 4 |
| 13 | Brenner Robert Chief Medical Officer | 2025-02-20 16:10:21 | 81,274 0 | 81,274 | Form 4 |
| 14 | JOHNSON DAVID LEE Chief Operating Officer | 2025-02-20 16:05:47 | 80,700 0 | 80,700 | Form 4 |
| 15 | Turner William D. Chief Development Officer | 2025-02-20 16:11:50 | 67,500 0 | 67,500 | Form 4 |
| 16 | Curley Joanne Chief Development Officer | 2023-08-23 17:57:54 | 26,962 0 | 26,962 | Form 4 |
| 17 | Cheng Andrew Director | 2025-05-16 16:05:20 | 14,000 0 | 14,000 | Form 4 |
| 18 | Morrison Scott W Director | 2025-05-16 16:06:33 | 14,000 0 | 14,000 | Form 4 |
| 19 | Hall Kimball Director | 2025-05-16 16:08:37 | 14,000 0 | 14,000 | Form 4 |
| 20 | SEIDENBERG BETH C Director | 2025-05-16 16:10:20 | 14,000 0 | 14,000 | Form 4 |
| 21 | MORRISSEY MICHAEL Director | 2025-05-16 16:11:14 | 14,000 0 | 14,000 | Form 4 |
| 22 | Oliger Christy J. Director | 2025-05-16 16:12:06 | 14,000 0 | 14,000 | Form 4 |
| 23 | Katabi Maha Director | 2025-05-16 16:13:51 | 14,000 0 | 14,000 | Form 4 |
| 24 | Lin Celia Chief Medical Officer | 2023-08-23 17:59:56 | 11,010 0 | 11,010 | Form 4 |
| 25 | Wolter Jonathan Chief Financial Officer | 2021-05-13 19:05:22 | 0 0 | 0 | Form 3 |